Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

A Multi-center, Randomized, Double-blind, Parallel-group Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 Fixed Dose Combination in Patients With Dyslipidemia and Hypertension

The purpose of this study is to determine superiority of YHP1701 comparing to each monotherapy in patient with hypertension and primary hypercholesterolemia.

Inclusion Criteria:

• Both man and woman who is over 19 years old
• Patient with dyslipidemia and hypertension

Exclusion Criteria:

• sSBP difference is ≥20 mmHg or sDBP difference is ≥10 mmHg
• A history of cardiovascular disease
• Rhabdomyolysis, myopathy
• Hypertension or hypercholesterolemia due to secondary causes
• Uncontrolled diabetes
• Evidence of hepatic or renal disease